Angelman Syndrome (AS) is a rare neuro-genetic disorder that affects the neurological development of an individual. It is characterized by severe developmental delays, intellectual disability, seizures, and other differences in physical and mental development.
Individuals with AS display a wide range of symptoms, including jerky movements, frequent laughter and smiling, difficulty with speech, motor delays, and sleep disturbances. Additionally, they may have problems with balance, coordination, hearing, and vision. People with AS typically have an overall happy disposition and are often described as being very loving and affectionate.
The cause of AS is not fully understood, but it is thought to be related to a genetic mutation or deletion on chromosome 15. This mutation causes a disruption in the normal functioning of the UBE3A gene, which has a role in controlling the production of certain proteins in the brain. This disruption can lead to the development of the symptoms associated with AS.
The most common symptom of AS is developmental delay, which may include delays in learning to walk, talk, and cognitive development. People with AS often have difficulty with problem-solving and abstract reasoning, as well as difficulty in communication. Additionally, individuals with AS may have seizures, sleep disturbances, and difficulty with balance and coordination.
Because of the wide range of symptoms associated with AS, individuals with the disorder require support and care to ensure that their needs are met. This may include therapies such as physical, occupational, and speech, as well as educational and behavioral interventions. Additionally, due to the genetic basis of AS, individuals may need medical management of their seizures and other medical issues.
In conclusion, Angelman Syndrome is a rare neuro-genetic disorder that has a wide range of physical and cognitive symptoms. People with AS typically have developmental delays, intellectual disability, seizures, and a happy disposition. The cause of AS is thought to be related to a genetic mutation or deletion on chromosome 15, which disrupts the normal functioning of the UBE3A gene. Individuals with AS require support and care to ensure that their needs are met, which may include therapies and educational and behavioral interventions.